EUVIMEDEUVIMED entdecken
Crossref

Clinical factors influencing the systolic blood pressure benefits of once-weekly semaglutide in patients with type 2 diabetes

Jorge Gabriel Ruiz-Sánchez, Roberto Miguel Sierra Poyatos, Bogdana Luiza Luca, Begoña Sánchez-Lechuga, Naiara Modroño Móstoles, Teresa Montoya Álvarez, Diego Meneses, Raquel Sánchez-Lopez, Carlos Casado Cases, Víctor Pérez de Arenaza Pozo, Clotilde Vázquez, Jersy Jair Cárdenas-Salas

Medicina Clínica · 2025-12 · 165 (6) · 107179

DOI: 10.1016/j.medcli.2025.107179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina Clínica, 2025-12. Verfasst von Jorge Gabriel Ruiz-Sánchez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain; Instituto de Investigación Sanitaria Fundación Jiménez-Díaz (…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptides, Blood Pressure, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Instituto de Investigación Sanitaria Fundación Jiménez Díaz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Glucagon-Like PeptidesBlood PressureHypertensionHypoglycemic AgentsHumansFemaleMiddle AgedMaleAgedDrug Administration ScheduleTreatment OutcomeGlucagon-Like Peptide 1Semaglutide

Stichwörter der Autor:innen

Blood pressureDiabetes tipo 2Hipertensión arterialHypertensionObesidadObesityPresión arterialSemaglutidaSemaglutideType 2 diabetes

Substanzen

Glucagon-Like PeptidesHypoglycemic AgentsGlucagon-Like Peptide 1Semaglutide

Autor:innen und Institutionen

  • Endocrinology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain; Instituto de Investigación Sanitaria Fundación Jiménez-Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), Hospital Universitario…
  • Endocrinology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain; Endocrinology Department, Hospital Universitario General de Villalba, Madrid, Spain.
  • Endocrinology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
  • Endocrinology Department, Hospital Universitario Infanta Elena, Madrid, Spain.
  • Endocrinology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain; Endocrinology Department, Hospital Universitario Infanta Elena, Madrid, Spain.

Förderung

  • Instituto de Investigación Sanitaria Fundación Jiménez Díaz

Zitieren

APA

Ruiz-Sánchez, J. G., Sierra Poyatos, R. M., Luiza Luca, B., Sánchez-Lechuga, B., Modroño Móstoles, N., Montoya Álvarez, T., Meneses, D., Sánchez-Lopez, R., Casado Cases, C., Pérez de Arenaza Pozo, V., Vázquez, C., & Cárdenas-Salas, J. J. (2025). Clinical factors influencing the systolic blood pressure benefits of once-weekly semaglutide in patients with type 2 diabetes. Medicina Clínica, 165(6), 107179. https://doi.org/10.1016/j.medcli.2025.107179

Vancouver

Ruiz-Sánchez JG, Sierra Poyatos RM, Luiza Luca B, Sánchez-Lechuga B, Modroño Móstoles N, Montoya Álvarez T, et al. Clinical factors influencing the systolic blood pressure benefits of once-weekly semaglutide in patients with type 2 diabetes. Medicina Clínica. 2025;165(6):107179. doi:10.1016/j.medcli.2025.107179

BibTeX
@article{RuizSnchez2025,
  author = {Ruiz-Sánchez, Jorge Gabriel and Sierra Poyatos, Roberto Miguel and Luiza Luca, Bogdana and Sánchez-Lechuga, Begoña and Modroño Móstoles, Naiara and Montoya Álvarez, Teresa and Meneses, Diego and Sánchez-Lopez, Raquel and Casado Cases, Carlos and Pérez de Arenaza Pozo, Víctor and Vázquez, Clotilde and Cárdenas-Salas, Jersy Jair},
  title = {Clinical factors influencing the systolic blood pressure benefits of once-weekly semaglutide in patients with type 2 diabetes},
  journal = {Medicina Clínica},
  year = {2025},
  volume = {165},
  number = {6},
  pages = {107179},
  doi = {10.1016/j.medcli.2025.107179}
}
Kostenlos starten →